

Clinical research and development services across the study lifecycle, including clinical operations, data management, biostatistics, medical writing, safety, and pharmacovigilance.

large_6b7e6aaf-3d46-496b-9e87-d42ae4bc98b2 (1).jpg

medium_6b7e6aaf-3d46-496b-9e87-d42ae4bc98b2 (1).jpg

small_6b7e6aaf-3d46-496b-9e87-d42ae4bc98b2 (1).jpg

thumbnail_6b7e6aaf-3d46-496b-9e87-d42ae4bc98b2 (1).jpg

6b7e6aaf-3d46-496b-9e87-d42ae4bc98b2 (1).jpg

01. Contract Research Organization (CRO)



Bioequivalence and bioavailability studies, comparative dissolution, pharmacokinetic calculations, and bioanalytical services.

large_fcd90b89-eb3a-4297-a42d-74464b42fe8c (1).jpg

medium_fcd90b89-eb3a-4297-a42d-74464b42fe8c (1).jpg

small_fcd90b89-eb3a-4297-a42d-74464b42fe8c (1).jpg

thumbnail_fcd90b89-eb3a-4297-a42d-74464b42fe8c (1).jpg

fcd90b89-eb3a-4297-a42d-74464b42fe8c (1).jpg

02. Bioequivalence Center (MARC-BE)

Integrated basic and translational research, including genomics, bioinformatics, molecular biology, immunology, microbiology, cell culture, and nanotechnology.

large_AGH46300 (1) 1 (1).jpg

medium_AGH46300 (1) 1 (1).jpg

small_AGH46300 (1) 1 (1).jpg

thumbnail_AGH46300 (1) 1 (1).jpg

AGH46300 (1) 1 (1).jpg

03. Bioscience Research Laboratories (BioLabs)

Dedicated clinical research facilities supporting Phase I–IV studies and complex clinical investigations.

large_IMG_0101 (1).jpg

medium_IMG_0101 (1).jpg

small_IMG_0101 (1).jpg

thumbnail_IMG_0101 (1).jpg

IMG_0101 (1).jpg

05. Clinical Research Site (MEDAXIS)

Clinical trial monitoring, quality oversight, GCP compliance, participant safety, and clinical data integrity.

large_2354841e-fa64-4980-84fe-4d47cb3aab9d (2).jpg

medium_2354841e-fa64-4980-84fe-4d47cb3aab9d (2).jpg

small_2354841e-fa64-4980-84fe-4d47cb3aab9d (2).jpg

thumbnail_2354841e-fa64-4980-84fe-4d47cb3aab9d (2).jpg

2354841e-fa64-4980-84fe-4d47cb3aab9d (2).jpg

04.Clinical Trials Monitoring & Quality Assurance Services (ClinGuard)

MARC-CRO is officially registered by the Central Administration of Research & Health Development, and the Egyptian Ministry of Health & Population (MOH). We conduct clinical trials under the Egyptian Drug Authority's (EDA) oversight. 

small_global-contract-research-organization-services-market.webp

thumbnail_global-contract-research-organization-services-market.webp

global-contract-research-organization-services-market.webp

Contract Research Organization

MARC Bioscience Research Laboratories are a leading provider of integrated basic and translational research. MARC’s multidisciplinary, highly motivated team of scientists and researchers is dedicated to adopting cutting edge technologies that can lead to patentable life-saving products.

medium_61553b754e5199b01e5e5137_Icon Design-07.png

small_61553b754e5199b01e5e5137_Icon Design-07.png

thumbnail_61553b754e5199b01e5e5137_Icon Design-07.png

61553b754e5199b01e5e5137_Icon Design-07.png

Bioscience Research Laboratories

MARC-BE was established in 2022. MARC-BE center is licensed by the Egyptian Drug Authority (EDA) and officially accredited by the GCC Health Council.  Our center boasts a highly trained and experienced team. MARC-BE has an excellent clinical site and its own fully equipped bio-analytical site, both comply with ICH- GCP/GLP requirements.


small_Bioequivalence-Studies.jpg

thumbnail_Bioequivalence-Studies.jpg

Bioequivalence-Studies.jpg

Bioequivalence Center

MARC for Medical Services and Scientific Research is a newly established integrative research center that aims to advance science by translating and applying scientific discoveries into practice. 

A word from our CEO 

Video Project 5.mp4

As a leading clinical research center in MENA region, M.A.R.C for Medical Services & Scientific Research, receives GCC Health Council Accreditation for its bioequivalence unit. Such accreditation represents a testament to our continuous innovation, commitment to quality healthcare, and advancing medical research in the region.

M.A.R.C receives GCC Health Council Accreditation for its bioequivalence unit.


medium_1715412448781.jpeg

small_1715412448781.jpeg

thumbnail_1715412448781.jpeg

1715412448781.jpeg

Bioequivalence Unit receives GCC Accreditation.

It was a great pleasure to participate in TCIS Africa 2024, that was held in Egypt . In light of this major event, MARC was thrilled to host TCIS members and committee on its premises, where we all expressed the shared belief that Africa's time has begun. It was a great opportunity for us to introduce our facilities and share with TCIS committee our objectives and future plans. Many possibilities for potential collaborations and mutual learning experiences were shared from both sides.
Active collaboration and Innovation are two of MARC's core values, and we were happy to share them with TCIS.

MARC center is proudly hosting TCIS attendees on its premises

large_DSC_8558.JPG

medium_DSC_8558.JPG

small_DSC_8558.JPG

thumbnail_DSC_8558.JPG

DSC_8558.JPG

MARC Host TCIS committee attendees on its premises 

we had the honor at MARC to welcome Prof. Abdel Nasser Singab, Professor of Pharmacognosy and the Founder and General Supervisor of the Center of Drug Discovery Research and Development at Ain Shams University,along with Dr. Ahmed Elissawy, Lecturer of Pharmacognosy and Manager of Center of Drug Disscovery research and development at Ain Shams University. It was a fruitful meeting where we had the chance to share the latest updates and our future plans.

MARC welcomes Prof. Abdel Nasser Singab, 

large_1716722520999.jpeg

medium_1716722520999.jpeg

small_1716722520999.jpeg

thumbnail_1716722520999.jpeg

1716722520999.jpeg

Egypt:
27 Northern Expansion, Polaris Complex,  
4th Industrial Zone, 6th of October City.     






for Feedbacks and Complains


MARC is an integrated organization for medical services and scientific research, bringing together specialized capabilities across clinical research, bioequivalence, and biosciences research.


large_bg_db41b3c3c9.jpg

medium_bg_db41b3c3c9.jpg

small_bg_db41b3c3c9.jpg

thumbnail_bg_db41b3c3c9.jpg

bg_db41b3c3c9.jpg